JOIN US IN OUR FIRESIDE CHAT
From Prototype to Precision at Scale: What It Takes to Manufacture the Next Generation of Minimally Invasive and Surgical Robotics Devices
Bringing next-generation surgical innovations to market takes more than a brilliant design—it takes a manufacturing partner that can deliver precision at scale, protect your IP, and help you avoid costly delays and rework.
In this fireside chat, you’ll hear firsthand from industry leaders and contract manufacturing experts on what truly sets the best OEM-partner relationships apart. From knowing the right time to engage with a manufacturing partner, to balancing quality and cost without compromise, this conversation will explore the often-overlooked factors that drive long-term success in robotic-assisted and minimally invasive surgical device manufacturing.
We’ll also tackle:
- Why early collaboration with a strategic contract manufacturing partner matters more than ever;
- The hidden risks of choosing the “lowest cost” option;
- How to navigate IP, contracts, and alignment before it’s too late; and
- What makes a contract manufacturing partner truly strategic.
Whether you’re an R&D leader, engineer, program manager, or sourcing executive, this candid and practical discussion will leave you better equipped to bring your innovations to life—faster, smarter, more reliably, and more cost-effectively.
MODERATOR
Steve Bell
Surgical Robotics Expert
PANELISTS
John Hoskins
CCO & CTO, Atalys
Jim Roady
Director of Enterprise Technology, Atalys
Tom Wenchell
CEO – Revmedica
TIME & PLACE
Wednesday, April 30, 2025
2:45 PM – 3:15 PM (EST)
Boston Convention & Exhibition Center
DeviceTalks Engineering Theater
415 Summer Street
Boston, MA 02210
WHY ATTEND
Gain rare insight into what it really takes to bring the next generation of minimally invasive and robotic-assisted surgical devices from prototype to full-scale production. This fireside chat brings together experts from both the OEM and manufacturing side to share hard-earned lessons, common pitfalls, and the operational strategies that make or break successful scale-ups. If you’re involved in R&D, engineering, operations, sourcing, or innovation leadership — this is a session you don’t want to miss.
WHO SHOULD ATTEND
This session is designed for decision-makers, engineers, and cross-functional teams responsible for advancing MedTech innovation. Ideal attendees include:
- Design and R&D engineers navigating DFM challenges.
- Sourcing and supply chain leaders evaluating resilient manufacturing partners.
- Operations and program managers planning for commercialization.
- Innovation and product executives driving go-to-market timelines.
Whether you’re with a startup pushing toward first product launch or part of a global OEM scaling next-gen surgical platforms, this session speaks directly to the realities of MedTech manufacturing today.
WHAT YOU’LL LEARN
Walk away with practical insights you can apply immediately, including:
- When and how to engage contract manufacturers for greatest impact.
- What true part scalability looks like — and how to achieve it.
- Balancing speed, quality, and cost in manufacturing complex components.
- How to avoid late-stage redesigns that derail timelines.
- What OEMs often overlook when selecting manufacturing partners.
This isn’t theory: It’s real-world experience from both sides of the table.
HOW THIS SESSION IMPACTS THE INDUSTRY
As the surgical robotics market evolves rapidly, device makers face unprecedented pressure to scale with speed and precision while managing cost and risk. This session will shine a light on what’s working — and what’s not — when it comes to building partnerships that power innovation at scale. By bringing together OEM and manufacturing leaders, this discussion aims to bridge the gap between design and delivery and help shape the future of surgical device commercialization.
This is more than a conversation. It’s a playbook for what’s next in MedTech manufacturing.
OUR SPEAKERS
STEVE BELL
Surgical Robotics Expert
Steve Bell is an expert in soft tissue robotics. He has over 26 years of surgical robotics experience. Today he is one of the industry’s leading voices in surgical robotics.
JOHN HOSKINS
CCO & CTO
John leads Atalys’ business development and technology organizations. His lifelong background in the market encompasses various senior executive roles at leading companies in key markets where he built deep relationships and knowledge of leading OEMs.
JIM ROADY
Director, Enterprise
Technology
With 35 years of experience in medical device manufacturing at world-leading OEMs and contract manufacturers, Jim brings unparalleled expertise and a passion for leveraging technology to create innovative and impactful solutions.
THOMAS WENCHELL
CEO, Revmedica
Tom is the CEO and Co-Founder of RevMedica, a medical device company based in Middletown, CT. RevMedica is developing a next-generation laparoscopic and robotic stapling platform. An engineer by training, Tom brings over 30 years of experience in the medical device industry.
